Radial extracorporeal shock wave versus diclofenac phonophoresis on myofascial trigger points of upper fibers of trapezius

Patients with myofascial pain not only suffer from decreased functional status as a result of the musculoskeletal pain but, also they suffer from impaired mood and decreased quality of life. The purpose of this study was to compare between the effect of radial extracorporeal shock wave therapy (rESWT) and diclofenac phonophoresis (PH) on pain intensity, threshold and neck functional abilities in patients with myofascial trigger points (MTrps) of upper fibers of trapezius. Methodology: Forty five patients of both genders aged from 18- 30 years old with MTrps of upper fibers of trapezius, were assigned randomly and equally into 3 groups: Group A: consisted of 15 patients received rESWT on upper fibers of trapezius in addition to conventional physical therapy treatment. Group B: consisted of 15 patients received PH of diclofenac sodium, in addition to conventional physical therapy treatment. Group C: consisted of 15 patients received the conventional physical therapy treatment only. Results: There was no significance difference between groups pre-treatment in all measured variables; while post-treatment measured values revealed that there was significance improvement in all measured variables in shockwave group at the expense of Diclofenac PH and control groups

DESIGN STUDY AND SIMULATION OF A DIGITAL FIBER COMMUNICATION SYSTEM USING (OPTISYSTEM.10)

Recent digital fiber optic communication systems address modulation and detection techniques for high spectral efficiency and robustness against transmission impairments. The proposed objective of this project is to design studies and analyze the simulation model of a Digital Fiber Communication System using (optisystem.10), as well as the front-end components and units used to implement them. Using the most suitable settings of the system which include laser transmitter with (1310nm) and (1550nm) wavelengths as input power (dBm), optical fiber with both (SM and MM) cable types as channel length (km),(RZ and NRZ) modulationand demodulation schemes to maximize spectral efficiency and power efficiency by encoding information are analyzed in order to evaluate their penalization over the signal qualityat the receiver.There are three different parameters will be investigated which are output power (dBm), noise figure (dB), and transmittance for the two types of fibers

PREVALENCE OF DIFFERENT HEPATITIS B VIRUS GENOTYPES AND RISK FACTORS ASSOCIATED AMONG SELECTED YEMENI PATIENTS WITH CHRONIC HEPATITIS B INFECTION

Background and aims: Hepatitis B virus infection is a significant public health crisis global. Hepatitis B virus genotyping is an important tool in epidemiological studies to determine the category and extent of treatment and to predict the outcome of chronic infections, for instance hepatocellular carcinoma and cirrhosis. The study designed to determine the prevalence of hepatitis B virus genotypes among Yemeni patients with chronic hepatitis B (CHB) and to evaluate some of the associated risk factors. Methods: Fifty patients (38 males, 12 females) with chronic hepatitis B from Al-Thawra Modern General Hospital, Al-Kuwait University Hospital, and AL-Gomhoria Hospital were included. HBV DNA was first detected by conventional PCR then HBV genotypes were determined using nested and multiplex PCR.  Results: Mixed HBV genotypes (A+B+C+D+E), (A+B+C+D+E+F), and  (A+B+C+D)  were found to be the most prevalent (60 %), it is followed by genotype D (16 %), genotype B (16%) and genotype A (8%), whereas C, E, and F genotype were not found individually among the study population. Blood transfusion was associated with mixed infection (χ2=13.06; p= 0.005). Conclusions: In assumption, this study demonstrates the general prevalence of hepatitis B virus genotypes among HBV-infected Yemeni hepatitis B patients who request medical consideration in a hospital. In mono-genotype HBV infection, genotype B and D were the most prevalent genotypes. In HBV mixed genotype infection, the A/B/C/D/E genotype was the most prevalent in the study area. In the future, based on genotype, clinical trials and treatment regimens must be individually assumed to efficiently manage chronic HBV infection. To this end, a prospective nationwide population study of HBV genotype spreading and clinical outcomes is suggested.                    Peer Review History: Received: 15 May 2021; Revised: 11 June; Accepted: 27 June, Available online: 15 July 2021 Academic Editor:  Ahmad Najib, Universitas Muslim Indonesia, Makassar, Indonesia, [email protected] UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency.  Received file:                Reviewer's Comments: Average Peer review marks at initial stage: 6.5/10 Average Peer review marks at publication stage: 7.5/10 Reviewer(s) detail: Dr. Salfarina Ramli,  Department of Pharmacology and Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Teknologi MARA, 42300 Puncak Alam, Selangor, Malaysia. [email protected]   Dr. Asia Selman Abdullah, University of Basrah, Iraq, [email protected] Similar Articles: EXPLOSION OF HEPATITIS B AND C VIRUSES AMONG HEMODIALYSIS PATIENTS AS A RESULT OF HEMODIALYSIS CRISIS IN YEMEN PREVALENCE AND GENOTYPING OF HEPATITIS C VIRUS IN HEMODIALYSIS PATIENTS AND EVALUATION OF HCV-CORE ANTIGEN TEST IN SCREENING PATIENTS FOR DIALYSIS IN SANA'A CITY, YEMEN PREVALENCE OF HBV AND HCV; AND THEIR ASSOCIATED RISK FACTORS AMONG PUBLIC HEALTH CENTER CLEANERS AT SELECTED PUBLIC HEALTH CENTERS IN SANA'A CITY-YEME